Talk with your care team.
Your care organization must take part in the program and offer Micelle 60.
Micelle 60 is being developed for participating care organizations. Your doctor decides with you if it fits your plan. Get ready for your visit. Learn to check your bottle.
The product
Micelle 60 is a hemp-derived CBD isolate softgel in development, with a planned label amount of 60 mg per softgel. A bottle is planned to hold 60 softgels. An independent lab will test each released lot. Micelle 60 is in development, to be supplied only through participating care organizations. It is not offered for retail sale. Medicare does not pay for it. If the product becomes available, your care organization would supply it only after your physician reviews it with you.
Your visit
Your care organization must take part in the program and offer Micelle 60.
Your doctor reviews your health and medicines with you. Your doctor writes down the joint decision.
If the product becomes available through your organization, it would give you the product and information sheet.
Check the bottle against its results online. Tell your care team if it does not match.
Follow up with your doctor as planned.
Prepare

Bring a full list, including things you use only sometimes.
Write down what you want your care team to explain.
Tell your care team about driving, work, care tasks, or tools you use.
Products containing any THC may affect a drug test; tell your doctor before you start if you are tested.
Patient discussion guide
Print or save this controlled one-page guide before a visit. It contains general preparation prompts, not individual medical advice.

Check your bottle
Find it on the label.
Enter it on this site or scan the code.
Read the results and any notices for that lot.
If the bottle and page do not match, do not use it. Tell Micelle and your care team.
Patient questions
Micelle 60 is a hemp-derived CBD isolate softgel in development, with a planned label amount of 60 mg per softgel. Each bottle is planned to hold 60 softgels. The final ingredient list and release details remain pending controlled evidence.
A micelle is a small form that can appear in fluid. The images show its design. They do not show a result in a person.
Micelle 60 is in development, to be supplied only through participating care organizations. It is not offered for retail sale.
If Micelle 60 is released and your care organization takes part, your doctor would decide with you whether it fits your plan.
Medicare does not pay for the product.
Each released lot will be tested, and its lot page will list total THC per container with the test method. The planned finished-product target is less than 0.4 mg combined total THC, including THCA, across the full container. The broader federal finished-product restriction begins December 11, 2026. That threshold alone does not establish product compliance, approval, release, or CMS eligibility.
Products containing any THC may affect a drug test; tell your doctor before you start if you are tested.
After release, find the lot number on the label, enter it on the Quality page or scan the code, then read that lot’s results, certificate status, and notices. Example records are available now to demonstrate the planned format.
For anything about your health, contact your care team. To report a product concern today, use the phone or correspondence route on the product-concern page. In an emergency, call 911.